Siegfried Holding AG
SFZN
株式のランク
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
株価
$88.34
時価総額
$3.87B
変化（1日）
1.68%
変化（1年）
-12.97%
国
CH
取引 Siegfried Holding AG (SFZN)
カテゴリー
Healthcare
Siegfried Holding AG（SFZN）のP/E比率
October 2026 時点のP/E比率 TTM 18.61
Siegfried Holding AG の最新の財務報告および株価によると、現在の P/E (TTM) は 18.61 です。2024 年末時点での P/E は 26.55 でした。
Siegfried Holding AG の P/E 比率の履歴（2002 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 18.61 | -3.99% |
| 2025 | 19.38 | -27.01% |
| 2024 | 26.55 | -17.81% |
| 2023 | 32.30 | 95.18% |
| 2022 | 16.55 | -57.71% |
| 2021 | 39.13 | -11.81% |
| 2020 | 44.37 | 21.56% |
| 2019 | 36.50 | 50.03% |
| 2018 | 24.33 | -24.83% |
| 2017 | 32.37 | 9.14% |
| 2016 | 29.66 | 49.88% |
| 2015 | 19.79 | 21.74% |
| 2014 | 16.25 | 38.10% |
| 2013 | 11.77 | -40.05% |
| 2012 | 19.63 | -42.83% |
| 2011 | 34.34 | -282.42% |
| 2010 | -18.83 | 157.44% |
| 2009 | -7.31 | 116.99% |
| 2008 | -3.37 | -131.41% |
| 2007 | 10.73 | -31.42% |
| 2006 | 15.64 | 25.79% |
| 2005 | 12.44 | -47.04% |
| 2004 | 23.48 | 195.46% |
| 2003 | 7.95 | 6.16% |
| 2002 | 7.49 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 23.30 | 25.22% |
DE
|
|
| 26.92 | 44.67% |
DE
|
|
| 55.58 | 198.70% |
JP
|
|
| 61.13 | 228.57% |
CH
|
|
| 34.87 | 87.43% |
IN
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。